RegMed XB and JSRM signed Memorandum of Understanding to collaborate in advancing regenerative medicine and cell & gene therapies worldwide

This MoU establishes a strategic framework for cooperation aimed at accelerating scientific research, technological development, and industrial applications in regenerative medicine, as well as cell and gene therapies.

JSRM is internationally recognized for its leadership in advancing the safe and ethical clinical application of regenerative medicine, including its work on guidance and policy development.

RegMed XB is committed to bridging scientific innovation and real-world implementation in regenerative medicine by fostering cross-sector collaboration and supporting globally harmonized approaches to research, development, and application.

Through this MoU, RegMed XB and JSRM reaffirm their shared commitment to advancing regenerative medicine through international cooperation, contributing to innovation, standardization, and societal trust in next-generation therapeutic technologies.

About RegMed XB

RegMed XB is a Dutch-Flemish consortium of public partners (such as universities and governments) and private partners (including health foundations and companies) working 

together to develop regenerative medicine solutions for major health challenges. The initiative promotes close collaboration between researchers and entrepreneurs to maximize societal and patient impact. In addition, the RegMed XB Pilot Factory provides essential infrastructure to scale up innovations toward GMP-grade products, bridging the gap between research and clinical application.

About the Japanese Society for Regenerative Medicine (JSRM)

JSRM is the largest academic society in regenerative medicine globally, with over 6,000 members spanning diverse fields, including basic and clinical sciences, tissue engineering, bioethics, regulatory science, and health policy. JSRM serves as a multidisciplinary platform for researchers, clinicians, industry leaders, and policymakers to collaborate on regenerative medicine development and implementation. The society actively engages in policy advocacy, develops industry standards, and hosts international academic conferences to drive scientific and regulatory advancements in regenerative medicine.

Website: https://en.jsrm.jp/